Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Docetaxel, Epirubicin, Cyclophosphamide/Navelbine, Capecitabine, Trastuzumab, Bevacizumab
Docetaxel, Epirubicin, Cyclophosphamide/Navelbine, Capecitabine, Trastuzumab, Bevacizumab
+1 more
Locations
1
Puerto Rico
Hospital Auxilio Mutuo Cancer Center
San Juan, PR, Puerto Rico
Start Date
March 1, 2011
Primary Completion Date
January 1, 2013
Completion Date
March 1, 2013
Last Updated
July 16, 2012
NCT07432633
NCT04551495
Lead Sponsor
Auxilio Mutuo Cancer Center
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions